JP-1366

· Onconic Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for JP-1366, covering 2022-07-13 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban [Phase 1]

See pricing